Taysha Gene Therapies, Inc. (TSHA) vs Tyra Biosciences, Inc. (TYRA)

Taysha Gene Therapies, Inc. and Tyra Biosciences, Inc. are both Biotechnology companies. Taysha Gene Therapies, Inc. and Tyra Biosciences, Inc. are of similar size ($1.6B and $1.5B). Across the 10 metrics below, Taysha Gene Therapies, Inc. leads on 5 and Tyra Biosciences, Inc. on 5.

Valuation

Metric TSHA TYRA Biotechnology median
P/E n/m n/m 7.88
P/S 146.12 n/m 11.47
P/B 4.45 4.07 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 111.68 n/m 10.73
Earnings yield (8.99%) (11.01%) (28.84%)
Free cash flow yield (8.07%) (7.64%) (23.03%)

Profitability

Metric TSHA TYRA Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (47.05%) (45.31%) (57.72%)
Return on assets (37.23%) (42.15%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric TSHA TYRA Biotechnology median
Revenue growth (TTM) 18.96% — 5.64%
EPS growth (last fiscal year) 5.56% (33.11%) —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric TSHA TYRA Biotechnology median
Debt to equity 0.13 0.00 0.00
Current ratio 17.76 14.91 4.73
Net debt to EBITDA 2.47 1.94 0.96

Dividend

Metric TSHA TYRA Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric TSHA TYRA Biotechnology median
Market cap 1.56b 1.54b 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack